MENU
GYRE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Gyre Therapeutics (GYRE) Ownership - Who owns Gyre Therapeutics?
Profile
Industry
N/A
Address
12770 High Bluff Drive
Phone
+1 619 949-3681
Employees
4
Web
https://www.gyretx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
956.06M
P/E Ratio
N/A
Total Cash
25.09M
Projected Growth
N/A
Total Debt
1.8M
Revenue
105.03M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.29
Total Debt/Equity
N/A
Revenue/Share
1.22 USD as % of share price
Fundamentals
GYRE
Capitalization
956M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
25.1M
Total Cash/Share
0.29
Total Debt
1.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.22%
Revenue
105M
ROE
N/A
Book Value
63.2M
P/B Ratio
15.13
Cash Flow
N/A
Earnings
-1.04
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
85K
Current Ratio
3.72
Current Revenue Per Employee
65186.70
Dividends Per Share - Security
N/A
EBITDA
11.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
96.24
Revenue To Assets
-70.92
Shares Held By Institutions
31.8M
Shares Outstanding - Current
85.8M
Total Liabilities
26.8M
Total Volume MTD
N/A
Value
-1
Gain YTD
-56.637
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
12770 High Bluff Drive
Phone
+1 619 949-3681
Employees
4
Web
https://www.gyretx.com